Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Collections
>
China Healthcare
COLLECTION
China Healthcare
Growing pains
Follow
Share
2.7k
Insights
1.0m
Views
12
Followers
Follow
Share
Regions
Sectors
Verticals
More Filters
Refresh
Top Picks Only
Recent
bearish
•
Saint Bella
•
23 Jul 2024 08:55
Pre-IPO Saint Bella - The Outlook for Future Performance Growth Is Highly Uncertain
Increasing contract liabilities ensure SAINT BELLA's short-term performance but declining fertility rate in China pose long-term challenge.We're...
Xinyao (Criss) Wang
Follow
112 Views
Share
bullish
•
Thematic (Sector/Industry)
•
22 Jul 2024 11:30
The Impact of the US Biosecure Act on India's Pharma Export Market
The US Biosecure Act may shift federal sourcing from China to India, boosting the country's pharmaceutical manufacturing and global competitiveness.
Nimish Maheshwari
Follow
305 Views
Share
bearish
•
Elpiscience Biopharmaceuticals
•
22 Jul 2024 08:55
Pre-IPO Elpiscience Biopharmaceuticals - Will Investors Still Buy in These Stories?
Elpiscience's strong capital operation capabilities are no longer enough as investors shift focus to cash flow and drug sales revenue. We have...
Xinyao (Criss) Wang
Follow
200 Views
Share
bullish
•
China Traditional Chinese Medicine
•
22 Jul 2024 00:42
Merger Arb Mondays (22 Jul) - China TCM, GA Pack, Huafa, Samson, CPMC, Fancl, Tatsuta, Capitol
This week, the highest gross spreads are HEC Pharma (122.5%), China TCM (31.8%), Asia Cement (12.6%), Canvest (11.1%), GA Pack (10.9%), Malaysia...
Arun George
Follow
316 Views
Share
bearish
•
InnoCare Pharma Ltd
•
21 Jul 2024 09:37
China Healthcare Weekly (July.21)-Rumor About Akeso, Takeover Bid for Legend Bio, InnoCare's Trouble
Revenue of Akeso's AK112 and AK104 in 2024 may fall short of expectations. Legend Bio got a takeover bid, which is "a test" for Genscript....
Xinyao (Criss) Wang
Follow
312 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.9
x